CTVA (Corteva, Inc.): Themes, ETFs, and Basket Ideas
CTVA is the ticker for Corteva, Inc.. This page covers what the company does, where it's heading, its approximate earnings and valuation, key competitors, the themes it belongs to, the ETFs that hold it, and similar stocks worth looking at.
What does Corteva, Inc. do?
Corteva is one of the largest agricultural input companies in the world, formed in 2019 when DowDuPont spun off its agriculture business. The company operates two main segments. Seed develops and sells genetically improved corn, soybean, canola, and other crop seeds. Crop Protection develops and sells herbicides, insecticides, fungicides, and biological products to protect crops from weeds, insects, and diseases.
Corteva is the largest pure-play agricultural input company on US markets after Monsanto was acquired by Bayer. The pure-play structure means revenue and earnings move directly with farmer income and commodity crop prices, providing cleaner exposure to agricultural cycles than diversified peers. Headquartered in Indianapolis, Indiana. Chuck Magro has been CEO since 2021.
Where is Corteva, Inc. heading?
1. Seed technology pipeline.
Corteva continues to advance seed traits (drought tolerance, herbicide tolerance, insect resistance, yield improvements). The Enlist platform (herbicide-tolerant soybeans) has been a particularly successful recent introduction. Seed pricing follows seed technology improvement; new traits drive premium pricing.
2. Biological products growth.
Biological crop protection (biopesticides, biostimulants, biofungicides) is one of the faster-growing agricultural input categories. Corteva has been investing in biological R&D and acquisitions. Biological products complement traditional chemistry and have favorable regulatory and ESG positioning.
3. Crop protection consolidation and competition.
Global crop protection is consolidated among Corteva, Bayer, BASF, Syngenta (ChemChina), and FMC. Pricing has been pressured at times by generic competition on older active ingredients. New patented chemistries support pricing.
4. Commodity crop cycle exposure.
Corteva's revenue tracks farmer income, which tracks commodity crop prices (corn, soybean, wheat). Cyclical fluctuations in crop prices create earnings volatility.
Risks worth tracking: Commodity crop price cycles affect farmer purchasing power and Corteva revenue. Weather conditions affect crop years and product demand. Regulatory pressure on certain herbicides (atrazine, paraquat) creates product-level risks.
Earnings and valuation (approximate, early 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Corteva, Inc.'s investor relations page or your broker.
- Revenue (TTM): ~$17 billion
- Operating margin: ~13%
- Net income (TTM): ~$1.5 billion
- EPS (TTM): ~$2.20
- P/E (TTM): ~30x
- Price to sales: ~2.5x
- Dividend yield: ~1.0%, with steady growth
- Free cash flow: ~$1.5 billion annually
- Seed segment: Larger and more profitable than crop protection
Corteva trades at a premium to traditional chemicals and materials peers reflecting the pure-play agricultural input exposure, the durable seed franchise, and the biologicals growth story. The multiple compresses during commodity crop downturns when farmer income weakens.
Themes CTVA belongs to
These are the investment theses CTVA naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.
CTVA's competitors
Seeds and traits
Bayer (after acquiring Monsanto in 2018) is the largest seed competitor and direct rival across corn, soybean, and other crops. Syngenta (owned by ChemChina) is also significant. BASF has a smaller seed business primarily through trait licensing.
Crop protection chemistry
Bayer, BASF, Syngenta, and FMC are the main competitors in global crop protection. The market is consolidated among these five (including Corteva) for patented active ingredients; generic competition is more fragmented for off-patent products.
Biological products
Various specialty biological companies (Marrone Bio Innovations, Indigo Ag, Pivot Bio) plus the agricultural majors increasingly investing in biologicals. The category is growing faster than traditional chemistry and is more fragmented.
Similar stocks
Other names that show up alongside CTVA in the same themes. Worth a look if you're thinking about diversification within a single thesis rather than concentration on one ticker.
Using CTVA in a Walnut basket
The most useful question to ask about a single stock is rarely “will it go up?”. It's “does this fit a thesis I actually believe in, and how do I size it alongside other stocks that fit the same thesis?” That's what Walnut is built for.
Open the AI assistant on Walnut and describe a thesis (for example: “the AI infrastructure buildout”, “dividend growth large-caps”, “global semiconductors”) where CTVA would naturally fit. The AI proposes 5 to 6 constituents with target weights, you review, and you can fund the basket through your broker once you're ready.
Build a basket around CTVA with Walnut
Use Corteva, Inc. as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What is Corteva's ticker symbol?
+
CTVA, listed on NYSE. Officially Corteva, Inc. Spun off from DowDuPont in 2019 as the pure-play agricultural input company. Headquartered in Indianapolis, Indiana. Trades during US market hours, available at every major US brokerage.
Who are Corteva's competitors?
+
By segment. Seeds: Bayer (after acquiring Monsanto), Syngenta (ChemChina), BASF. Crop protection chemistry: Bayer, BASF, Syngenta, FMC. Biological products: various specialty biological companies plus agricultural majors increasingly investing in biologicals. Global agricultural inputs are consolidated among five large players.
Is Corteva a good cyclical play?
+
Yes. Corteva's revenue tracks farmer income, which tracks commodity crop prices. The pure-play structure provides cleaner agricultural cycle exposure than diversified industrial peers. Earnings are volatile across commodity cycles but the seed franchise and biologicals growth provide structural support across cycles.
What is Corteva's P/E ratio?
+
Approximately 30x trailing twelve months as of early 2026. Premium reflecting the pure-play agricultural input structure, the durable seed franchise, and the biologicals growth story. The multiple compresses during commodity crop downturns.
What does Corteva do?
+
Corteva is one of the largest agricultural input companies in the world. Two main segments. Seed: genetically improved corn, soybean, canola, and other crop seeds. Crop Protection: herbicides, insecticides, fungicides, and biological products. The company is the pure-play agricultural input spinoff from DowDuPont.
Who owns the most Corteva stock?
+
Major institutional holders include Vanguard (~9%), BlackRock (~7%), and State Street (~4%). Insider ownership is low. Corteva is broadly institutionally owned and widely held in agricultural-themed and materials-focused funds.
Which ETFs have the most Corteva exposure?
+
MOO (VanEck Agribusiness) holds CTVA at ~8-10%, one of MOO's largest holdings. PAGG (Invesco Global Agriculture) holds CTVA at similar weight. XLB (Materials sector) holds CTVA at modest weight (~3-4%). VOO holds CTVA at ~0.1%. Agricultural-themed ETFs are the most concentrated way to gain CTVA exposure passively.
Which thematic baskets typically include Corteva?
+
One theme on Walnut: Agriculture (largest pure-play US agricultural input company; seeds, crop protection chemistry, biological products). CTVA is often paired with DE in agricultural baskets, providing the input layer alongside Deere's equipment layer.
How much of MOO is Corteva?
+
Approximately 8-10% as of early 2026. CTVA is consistently a top-3 MOO holding, often the largest single holding by weight given its size as the leading pure-play US agricultural input company. The high MOO weight makes the ETF a meaningful CTVA proxy.
Is Corteva in the S&P 500?
+
Yes. CTVA was added to the S&P 500 in June 2019 following the DowDuPont spinoff. It is typically a top-200 S&P 500 holding by market cap.
What is Corteva's market cap?
+
Approximately $45 billion as of early 2026. Market cap has been volatile across the agricultural cycle since the 2019 spinoff. Bull cycles (high crop prices, strong farmer income) support multiple expansion; current cycle is in a softer phase as crop prices have come off 2022 peaks.
Does Corteva pay a dividend?
+
Yes. CTVA yields approximately 1.0% as of early 2026, paid quarterly. The dividend has been raised steadily since the 2019 spinoff. Capital allocation has been balanced between dividend growth, share buybacks, and R&D reinvestment.
What is the Enlist seed platform?
+
Enlist is Corteva's proprietary trait technology for soybeans and corn that tolerates 2,4-D choline herbicide. The Enlist soybean platform has been a particularly successful recent introduction, gaining significant share in US soybean acres. Enlist's success demonstrates Corteva's ability to drive premium pricing through trait technology.
Should I own Corteva directly or through MOO?
+
Both common. Direct CTVA gives concentrated agricultural input exposure with leverage to the seed and crop protection cycle. MOO includes CTVA at ~8-10% along with DE, BG (Bunge), and other agricultural names. Many Walnut users hold both CTVA and DE directly in agricultural baskets because the inputs (CTVA) and equipment (DE) thesis are distinct cycles.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Corteva, Inc.'s investor relations page or your broker before making investment decisions.